E-viri
PDF
Recenzirano
Odprti dostop
-
Malespin, Miguel H.; Barritt, Alfred Sidney; Watkins, Stephanie E.; Schoen, Cheryl; Tincopa, Monica A.; Corbin, Karen D.; Mospan, Andrea R.; Munoz, Breda; Trinh, Huy N.; Weiss, L. Michael; Reddy, K. Rajender; Loomba, Rohit; Kemmer, Nyingi; Lok, Anna S.
Clinical gastroenterology and hepatology 20, Številka: 10Journal Article
First-line treatment for nonalcoholic fatty liver disease (NAFLD) focuses on weight loss through lifestyle modifications.1,2 Weight loss ≥5% results in reduction of steatosis and weight loss ≥10% has been associated with improvement in hepatic inflammation and fibrosis.3 The incidence and sustainability of weight loss among patients with NAFLD were estimated and associating factors identified.
